Impact of acute malaria on pre-existing antibodies to viral and vaccine antigens in mice and humans

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Banga, Simran ^a,f   Coursen, Jill D ^b   Portugal, Silvia ^b   Tran, Tuan M ^b   Hancox, Lisa ^a   Ongoiba, Aissata ^c   Traore, Boubacar ^c   Doumbo, Ogobara K ^c   Huang, Chiung Yu ^d   Harty, John T ^a,e   Crompton, Peter D ^b  

^a UNIVERSITY OF IOWA   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c Sociétés   (Mali)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e UNIVERSITY OF IOWA   (United States)

^f INDIANA UNIVERSITY EAST   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VACCINE; IMMUNOGLOBULIN G ANTIBODY; MEASLES VACCINE; TETANUS TOXOID; B CELL ACTIVATING FACTOR RECEPTOR; MALARIA VACCINE; PARASITE ANTIGEN; PROTOZOON ANTIBODY; TNFRSF13C PROTEIN, MOUSE; VIRUS ANTIBODY; VIRUS ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; INBRED MOUSE STRAIN; INFLUENZA A (H1N1); LISTERIOSIS; LYMPHOCYTIC CHORIOMENINGITIS; MAJOR CLINICAL STUDY; MALARIA; MALARIA FALCIPARUM; MALE; MALIAN; MOUSE; NONHUMAN; OUTBRED MOUSE STRAIN; PLASMODIUM YOELII INFECTION; PRESCHOOL CHILD; ANIMAL; ANTIBODY PRODUCTION; APOPTOSIS; BAGG ALBINO MOUSE; C57BL MOUSE; DEMOGRAPHY; ERYTHROCYTE; HALF LIFE TIME; IMMUNITY; IMMUNIZATION; IMMUNOLOGY; KINETICS; MALI; METABOLISM; PATHOLOGY; PLASMA CELL; PLASMODIUM YOELII; SEASON; SHEEP;

MALIA; MUS; PLASMODIUM YOELII;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIBODIES, VIRAL; ANTIBODY FORMATION; ANTIGENS, PROTOZOAN; ANTIGENS, VIRAL; APOPTOSIS; B-CELL ACTIVATION FACTOR RECEPTOR; CHILD, PRESCHOOL; DEMOGRAPHY; ERYTHROCYTES; FEMALE; HALF-LIFE; HUMANS; IMMUNITY; IMMUNIZATION; KINETICS; MALARIA; MALARIA VACCINES; MALE; MALI; MICE, INBRED BALB C; MICE, INBRED C57BL; PLASMA CELLS; PLASMODIUM YOELII; SEASONS; SHEEP;

EID: 84928740440     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0125090     Document Type: Article

References (36)

1. Keja K, Chan C, Hayden G, Henderson RH. Expanded programme on immunization. World health statistics quarterly Rapport trimestriel de statistiques sanitaires mondiales. 1988; 41(2):59-63. PubMed PMID: 3176515.
2. Okwo-Bele JM, Cherian T. The expanded programme on immunization: a lasting legacy of smallpox eradication. Vaccine. 2011; 29 Suppl 4:D74-9. doi: 10.1016/j.vaccine.2012.01.080 PubMed PMID: 22486980.
3. Black RE, Cousens S, Johnson HL, Lawn JE, Rudan I, Bassani DG, et al. Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet. 2010; 375(9730):1969-87. doi: 10.1016/S0140-6736(10)60549-1 PubMed PMID: 20466419.
4. Centers for Disease C, Prevention. Global routine vaccination coverage, 2011. MMWR Morbidity and mortality weekly report. 2012; 61(43):883-5. PubMed PMID: 23114256.
5. Greenwood BM, Bradley-Moore AM, Bryceson AD, Palit A. Immunosuppression in children with malaria. Lancet. 1972; 1(7743):169-72. PubMed PMID: 4109547.
6. Plotkin SA. Correlates of protection induced by vaccination. Clin Vaccine Immunol. 2010; 17(7):1055-65. doi: 10.1128/CVI.00131-10 PubMed PMID: 20463105; PubMed Central PMCID: PMC2897268.
7. Tarlinton D, Good-Jacobson K. Diversity among memory B cells: origin, consequences, and utility. Science. 2013; 341(6151):1205-11. doi: 10.1126/science.1241146 PubMed PMID: 24031013.
8. Amanna IJ, Carlson NE, Slifka MK. Duration of humoral immunity to common viral and vaccine antigens. N Engl J Med. 2007; 357(19):1903-15. PubMed PMID: 17989383.
9. Crompton PD, Kayala MA, Traore B, Kayentao K, Ongoiba A, Weiss GE, et al. A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarray. Proc Natl Acad Sci U S A. 2010; 107(15):6958-63. doi: 10.1073/pnas.1001323107 PubMed PMID: 20351286; PubMed Central PMCID: PMC2872454.
10. Tran TM, Li S, Doumbo S, Doumtabe D, Huang CY, Dia S, et al. An intensive longitudinal cohort study of Malian children and adults reveals no evidence of acquired immunity to Plasmodium falciparum infection. Clin Infect Dis. 2013; 57(1):40-7. doi: 10.1093/cid/cit174 PubMed PMID: 23487390; PubMed Central PMCID: PMC3669526.
11. Portugal S, Pierce SK, Crompton PD. Young lives lost as B cells falter: what we are learning about antibody responses in malaria. J Immunol. 2013; 190(7):3039-46. doi: 10.4049/jimmunol.1203067 PubMed PMID: 23526829.
12. Butler NS, Moebius J, Pewe LL, Traore B, Doumbo OK, Tygrett LT, et al. Therapeutic blockade of PDL1 and LAG-3 rapidly clears established blood-stage Plasmodium infection. Nat Immunol. 2011; 13 (2):188-95. Epub 2011/12/14. ni.2180 [pii]doi: 10.1038/ni.2180 PubMed PMID: 22157630.
13. Weiss GE, Crompton PD, Li S, Walsh LA, Moir S, Traore B, et al. Atypical memory B cells are greatly expanded in individuals living in a malaria-endemic area. J Immunol. 2009; 183(3):2176-82. Epub 2009/07/14. jimmunol.0901297 [pii]doi: 10.4049/jimmunol.0901297 PubMed PMID: 19592645.
14. Illingworth J, Butler NS, Roetynck S, Mwacharo J, Pierce SK, Bejon P, et al. Chronic exposure to Plasmodium falciparum is associated with phenotypic evidence of B and T cell exhaustion. J Immunol. 2013; 190(3):1038-47. doi: 10.4049/jimmunol.1202438 PubMed PMID: 23264654; PubMed Central PMCID: PMC3549224.
15. Ng DH, Skehel JJ, Kassiotis G, Langhorne J. Recovery of an antiviral antibody response following attrition caused by unrelated infection. PLoS Pathog. 2014; 10(1):e1003843. doi: 10.1371/journal.ppat.1003843 PubMed PMID: 24391499; PubMed Central PMCID: PMC3879355.
16. Rickert RC, Jellusova J, Miletic AV. Signaling by the tumor necrosis factor receptor superfamily in Bcell biology and disease. Immunol Rev. 2011; 244(1):115-33. doi: 10.1111/j.1600-065X.2011.01067.x PubMed PMID: 22017435; PubMed Central PMCID: PMC3202302.
17. Measles vaccines: WHO position paper. Releve epidemiologique hebdomadaire / Section d'hygiene du Secretariat de la Societe des Nations = Weekly epidemiological record / Health Section of the Secretariat of the League of Nations. 2009; 84(35):349-60. PubMed PMID: 19714924.
18. Hepatitis B vaccines. Releve epidemiologique hebdomadaire / Section d'hygiene du Secretariat de la Societe des Nations = Weekly epidemiological record / Health Section of the Secretariat of the League of Nations. 2009; 84(40):405-19. PubMed PMID: 19817017.
19. Tetanus vaccine. Releve epidemiologique hebdomadaire / Section d'hygiene du Secretariat de la Societe des Nations = Weekly epidemiological record / Health Section of the Secretariat of the League of Nations. 2006; 81(20):198-208. PubMed PMID: 16710950.
20. WHO. Immunization Summary. 2012:106.
21. Wolters KL, Dehmel H. Abschlies- sende untersuchungen uber die Tetanus Prophylaxe durch active Immunisierung. Zeitschrift fur Hyeitschrift. 1942; 124:326-32.
22. Chen RT, Markowitz LE, Albrecht P, Stewart JA, Mofenson LM, Preblud SR, et al. Measles antibody: reevaluation of protective titers. J Infect Dis. 1990; 162(5):1036-42. PubMed PMID: 2230231.
23. Jack AD, Hall AJ, Maine N, Mendy M, Whittle HC. What level of hepatitis B antibody is protective? J Infect Dis. 1999; 179(2):489-92. doi: 10.1086/314578 PubMed PMID: 9878036.
24. Crompton PD, Traore B, Kayentao K, Doumbo S, Ongoiba A, Diakite SA, et al. Sickle Cell Trait Is Associated with a Delayed Onset of Malaria: Implications for Time-to-Event Analysis in Clinical Studies of Malaria. J Infect Dis. 2008; 198(9):1265-75. Epub 2008/08/30. doi: 10.1086/592224 PubMed PMID: 18752444.
25. Dai B, Chen ZH, Liu QC, Wu T, Guo CY, Wang XZ, et al. Duration of immunity following immunization with live measles vaccine: 15 years of observation in Zhejiang Province, China. Bull World Health Organ. 1991; 69(4):415-23. PubMed PMID: 1934235; PubMed Central PMCID: PMC2393239.
26. Amanna IJ, Slifka MK. Mechanisms that determine plasma cell lifespan and the duration of humoral immunity. Immunol Rev. 2010; 236:125-38. doi: 10.1111/j.1600-065X.2010.00912.x PubMed PMID: 20636813.
27. Minta DK, Traore AM, Soucko AK, Dembele M, Coulibaly Y, Dicko MS, et al. [Mortality and morbidity of tetanus in the infectious diseases department, Point G teaching hospital, in Bamako, Mali (2004-2009)]. Bulletin de la Societe de pathologie exotique. 2012; 105(1):58-63. doi: 10.1007/s13149-011-0204-y PubMed PMID: 22228429.
28. Sauerwein RW, Roestenberg M, Moorthy VS. Experimental human challenge infections can accelerate clinical malaria vaccine development. Nat Rev Immunol. 2011; 11(1):57-64. Epub 2010/12/24. nri2902 [pii]doi: 10.1038/nri2902 PubMed PMID: 21179119.
29. Amanna IJ, Hammarlund E, Lewis MW, Slifka MK. Impact of infection or vaccination on pre-existing serological memory. Human immunology. 2012; 73(11):1082-6. doi: 10.1016/j.humimm.2012.07.328 PubMed PMID: 22902392; PubMed Central PMCID: PMC3478407.
30. Kinyanjui SM, Conway DJ, Lanar DE, Marsh K. IgG antibody responses to Plasmodium falciparum merozoite antigens in Kenyan children have a short half-life. Malar J. 2007; 6:82. Epub 2007/06/30. 1475-2875-6-82 [pii]doi: 10.1186/1475-2875-6-82 PubMed PMID: 17598897.
31. Rogers NJ, Hall BS, Obiero J, Targett GA, Sutherland CJ. A model for sequestration of the transmission stages of Plasmodium falciparum: adhesion of gametocyte-infected erythrocytes to human bone marrow cells. Infect Immun. 2000; 68(6):3455-62. Epub 2000/05/19. PubMed PMID: 10816498.
32. Nduati E, Gwela A, Karanja H, Mugyenyi C, Langhorne J, Marsh K, et al. The plasma concentration of the B cell activating factor is increased in children with acute malaria. J Infect Dis. 2011; 204(6):962-70. Epub 2011/08/19. jir438 [pii]doi: 10.1093/infdis/jir438 PubMed PMID: 21849293.
33. Bernasconi NL, Traggiai E, Lanzavecchia A. Maintenance of serological memory by polyclonal activation of human memory B cells. Science. 2002; 298(5601):2199-202. doi: 10.1126/science.1076071 PubMed PMID: 12481138.
34. Weiss GE, Traore B, Kayentao K, Ongoiba A, Doumbo S, Doumtabe D, et al. The Plasmodium falciparum-specific human memory B cell compartment expands gradually with repeated malaria infections. PLoS Pathog. 2010; 6(5):e1000912. Epub 2010/05/27. doi: 10.1371/journal.ppat.1000912 PubMed PMID: 20502681.
35. Donati D, Mok B, Chene A, Xu H, Thangarajh M, Glas R, et al. Increased B cell survival and preferential activation of the memory compartment by a malaria polyclonal B cell activator. J Immunol. 2006; 177 (5):3035-44. Epub 2006/08/22. 177/5/3035 [pii]. PubMed PMID: 16920940.
36. WHO. World Malaria Report 2013. 2013:284.